Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal rod cell | 9 studies | 51% ± 19% | |
oligodendrocyte | 6 studies | 23% ± 6% | |
retinal cone cell | 5 studies | 25% ± 8% | |
GABAergic neuron | 3 studies | 30% ± 13% | |
glutamatergic neuron | 3 studies | 39% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 687.14 | 653 / 653 | 100% | 11.59 | 603 / 605 |
kidney | 100% | 396.04 | 89 / 89 | 88% | 10.47 | 790 / 901 |
brain | 99% | 1341.63 | 2607 / 2642 | 87% | 7.32 | 616 / 705 |
ovary | 82% | 173.42 | 148 / 180 | 97% | 11.84 | 415 / 430 |
lung | 89% | 230.59 | 512 / 578 | 60% | 3.74 | 697 / 1155 |
prostate | 96% | 241.89 | 235 / 245 | 43% | 1.67 | 215 / 502 |
breast | 61% | 161.03 | 281 / 459 | 76% | 6.82 | 854 / 1118 |
uterus | 58% | 107.21 | 99 / 170 | 47% | 3.40 | 216 / 459 |
spleen | 100% | 593.55 | 241 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 6.82 | 24 / 29 |
pancreas | 33% | 43.60 | 109 / 328 | 43% | 1.90 | 77 / 178 |
eye | 0% | 0 | 0 / 0 | 76% | 6.69 | 61 / 80 |
bladder | 48% | 83.71 | 10 / 21 | 22% | 1.31 | 112 / 504 |
heart | 67% | 130.87 | 576 / 861 | 0% | 0 | 0 / 0 |
intestine | 60% | 109.09 | 577 / 966 | 7% | 0.33 | 37 / 527 |
peripheral blood | 65% | 202.91 | 602 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 17% | 22.16 | 44 / 258 | 47% | 2.21 | 109 / 230 |
tonsil | 0% | 0 | 0 / 0 | 58% | 5.14 | 26 / 45 |
esophagus | 44% | 58.76 | 639 / 1445 | 11% | 0.49 | 21 / 183 |
stomach | 40% | 51.55 | 143 / 359 | 6% | 0.22 | 16 / 286 |
skin | 11% | 15.07 | 208 / 1809 | 29% | 1.31 | 139 / 472 |
adipose | 36% | 57.39 | 433 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 16% | 22.00 | 216 / 1335 | 0% | 0 | 0 / 0 |
liver | 1% | 1.97 | 2 / 226 | 11% | 0.63 | 43 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_1990009 | Biological process | retinal cell apoptotic process |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0007603 | Biological process | phototransduction, visible light |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0042622 | Cellular component | photoreceptor outer segment membrane |
GO_0097381 | Cellular component | photoreceptor disc membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0047555 | Molecular function | 3',5'-cyclic-GMP phosphodiesterase activity |
GO_0004115 | Molecular function | 3',5'-cyclic-AMP phosphodiesterase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PDE6B |
Protein name | Phosphodiesterase 6B Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta (GMP-PDE beta) (EC 3.1.4.35) |
Synonyms | PDEB |
Description | FUNCTION: Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP . Necessary for the formation of a functional phosphodiesterase holoenzyme (By similarity). Involved in retinal circadian rhythm photoentrainment via modulation of UVA and orange light-induced phase-shift of the retina clock (By similarity). May participate in processes of transmission and amplification of the visual signal . . |
Accessions | ENST00000465426.5 ENST00000461490.1 C9J628 ENST00000255622.10 [P35913-2] H7C4P9 ENST00000429163.6 [P35913-3] C9J7V6 ENST00000471824.6 ENST00000496514.6 [P35913-1] H7C4F7 P35913 ENST00000487902.5 |